Market Failure and the Poverty of New Drugs in Maternal Health

Résumé fourni par la source

A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal deaths each year, it is high time to address this issue. [Policy Forum January 2008, Volume 5, Issue 1].

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.